ANALYSIS OF O6-METILGUANINE-ADN-METILTRANSFERASE (MGMT) METHYLATION, 1P/19Q LOSS AND P53 STATUS IN GLIOMA TUMORS

被引：0
|
作者：
de Lope, A. Rodriguez [1 ]
Ruano, Y. [1 ]
Vicente, Y. [1 ]
Campos-Martin, Y. [1 ]
Perez-Magan, E. [1 ]
Juarez, R. [1 ]
Fuentes, D. [1 ]
Mollejo, M. [1 ]
Hernandez-Moneo, J. [1 ]
Melendez, B. [1 ]
机构：
[1] Hosp Virgen Salud, Toledo, Spain
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1128 / 1128
页数：1
相关论文
共 50 条
  • [31] 1p/19q Loss of Heterozygoty Patterns in Infiltrative Gliomas
    Durand, K. A.
    Weinbreck, N. J.
    Guillaudeau, A. N.
    Pommepuy, I. S.
    Caire, F. R.
    Robert, S. A.
    Chaunavel, A. L.
    Labrousse, F. J.
    MODERN PATHOLOGY, 2009, 22 : 329A - 329A
  • [32] 1p/19q Loss of Heterozygoty Patterns in Infiltrative Gliomas
    Durand, K. A.
    Weinbreck, N. I.
    Guillaudeau, A. N.
    Pommepuy, I. S.
    Caire, F. R.
    Robert, S. A.
    Chaunavel, A. L.
    Labrousse, F. J.
    LABORATORY INVESTIGATION, 2009, 89 : 329A - 329A
  • [33] Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma
    Aldape, Kenneth
    Burger, Peter C.
    Perry, Arie
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (02) : 242 - 251
  • [34] Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas
    Sanson, M
    Leuraud, P
    Marie, Y
    Delattre, JY
    Hoang-Xuan, K
    ANNALS OF NEUROLOGY, 2002, 52 (01) : 105 - 107
  • [35] Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors:: A clinicopathological study using fluorescence in situ hybridization
    Jeon, Yoon Kyung
    Park, Kyeongmee
    Park, Chul Ki
    Paek, Sun Ha
    Jung, Hee Won
    Park, Sung-Hye
    NEUROPATHOLOGY, 2007, 27 (01) : 10 - 20
  • [36] IDH Mutations, MGMT Methylation and 1p/19q Status Provides Better Diagnosis and Survival Prediction in an Indian Cohort of Diffuse Gliomas
    Majumdar, A.
    Katara, R.
    Bhardwaj, M.
    Verma, A.
    Sharma, D. K.
    Kumar, S.
    Kini, L.
    Pandita, A.
    Singh, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1188 - 1188
  • [37] Combined Immunohistochemistry for ATRX and p53 is Sensitive and Specific in Predicting 1p/19q Status in IDH- mutant Diffuse Gliomas
    Kam, Kwok Ling
    Horbinski, Craig
    Bigio, Eileen
    Lu, Xinyan
    Sukhanova, Madina
    Brat, Daniel
    Appin, Christina
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 533 - 533
  • [38] MGMT PROMOTER HYPERMETHYLATION AND P53 IMMUNOHISTOCHEMISTRY PREDICT OUTCOME FOLLOWING TEMOZOLOMIDE FOR RECURRENT 1P/19Q NON-DELETED ANAPLASTIC (OLIGO)ASTROCYTOMA
    Sadones, J.
    Michotte, A.
    Veld, P. In't
    Chaskis, C.
    Menten, J.
    Joosens, E.
    Strauven, T.
    Califice, S.
    De Greve, J.
    Neyns, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1129 - 1129
  • [39] Intratumoral heterogeneity of 1p/19q codeletion in brain tumors.
    Martinez-Garcia, Maria
    Lara, Mar
    Espinet, Blanca
    Salido, Marta
    Bellosillo, Beatriz
    Carmen Vela, Maria
    Vilarino, Noella
    Taus, Alvaro
    Mojal, Sergi
    Rovira, Ana
    Albanell, Joan
    Alameda, Francine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Clinical, histological, and immunohistochemical features predicting 1p/19q loss of heterozygosity in oligodendroglial tumors
    Kim, SH
    Kim, H
    Kim, TS
    ACTA NEUROPATHOLOGICA, 2005, 110 (01) : 27 - 38
12345